John E. Brown

634 total citations
31 papers, 521 citations indexed

About

John E. Brown is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, John E. Brown has authored 31 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Toxicology. Recurrent topics in John E. Brown's work include Bioactive Compounds and Antitumor Agents (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Cancer therapeutics and mechanisms (3 papers). John E. Brown is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Cancer therapeutics and mechanisms (3 papers). John E. Brown collaborates with scholars based in United Kingdom, United States and Kenya. John E. Brown's co-authors include Roger M. Phillips, Colin W. Wright, Paméla Pollet, Jonathan Addae-Kyereme, Simon L. Croft, Howard Kendrick, Ronald D. Snyder, Stephen E. Clarke, Christine Beedham and Tariq Shah and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Journal of Medicinal Chemistry.

In The Last Decade

John E. Brown

26 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Brown United Kingdom 12 281 163 86 45 42 31 521
Amin Mirza United Kingdom 15 399 1.4× 229 1.4× 54 0.6× 17 0.4× 82 2.0× 21 738
João F. S. Carvalho Portugal 9 287 1.0× 182 1.1× 36 0.4× 41 0.9× 54 1.3× 12 522
Anton E.P. Adang Netherlands 19 600 2.1× 228 1.4× 80 0.9× 20 0.4× 126 3.0× 26 949
Zeki Topçu Türkiye 16 334 1.2× 218 1.3× 31 0.4× 57 1.3× 53 1.3× 33 596
Manolis A. Fousteris Greece 16 273 1.0× 341 2.1× 37 0.4× 40 0.9× 97 2.3× 40 590
B. R. Winterhalter Germany 10 168 0.6× 121 0.7× 25 0.3× 27 0.6× 141 3.4× 15 396
Dimitar Jakimov Serbia 17 262 0.9× 299 1.8× 76 0.9× 38 0.8× 101 2.4× 69 711
Shankar M. Singh Canada 16 314 1.1× 330 2.0× 33 0.4× 32 0.7× 52 1.2× 33 826
Sotiris S. Nikolaropoulos Greece 16 336 1.2× 328 2.0× 25 0.3× 43 1.0× 105 2.5× 49 637
Manus Ipek United States 12 143 0.5× 252 1.5× 48 0.6× 14 0.3× 80 1.9× 14 511

Countries citing papers authored by John E. Brown

Since Specialization
Citations

This map shows the geographic impact of John E. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Brown more than expected).

Fields of papers citing papers by John E. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Brown. The network helps show where John E. Brown may publish in the future.

Co-authorship network of co-authors of John E. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Brown. A scholar is included among the top collaborators of John E. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Brown. John E. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rentschler, Mark E., et al.. (2025). Unexpected Discovery of Small Bowel Angiosarcoma Amidst the Management of Severe Polytrauma: A Case Report. Cureus. 17(2). e79324–e79324.
2.
Danson, Sarah, et al.. (2024). CN64 Three-year evaluation of an immunotherapy late effects screening clinic. Annals of Oncology. 35. S1188–S1188. 1 indexed citations
3.
Cerling, Thure E., et al.. (2022). 14-Carbon demonstrates that some illegal ivory is being taken from government stockpiles. Proceedings of the National Academy of Sciences. 119(44). e2211550119–e2211550119.
4.
Wasser, Samuel K., Charles J. Wolock, Mary K. Kuhner, et al.. (2022). Elephant genotypes reveal the size and connectivity of transnational ivory traffickers. Nature Human Behaviour. 6(3). 371–382. 12 indexed citations
5.
Gresley, Adam Le, et al.. (2016). Synthesis, analysis and biological evaluation of novel indolquinonecryptolepine analogues as potential anti-tumour agents. Organic & Biomolecular Chemistry. 14(11). 3069–3079. 20 indexed citations
6.
Brown, John E., et al.. (2013). PR and Communication in Local Government and Public Services. 8 indexed citations
7.
Tan, S Y & John E. Brown. (2006). Rudolph Virchow (1821-1902): "pope of pathology".. PubMed. 47(7). 567–8. 11 indexed citations
8.
Mitch, David, John E. Brown, & Marco H. D. van Leeuwen. (2004). Origins of the modern career. Ashgate eBooks. 15 indexed citations
9.
11.
Snyder, Ronald D. & John E. Brown. (2002). EVIDENCE FOR AND ROLE OF THE DIMETHYLAMINO GROUP IN TAMOXIFEN DNA INTERCALATION IN INTACT CHINESE HAMSTER V79 CELLS. Drug and Chemical Toxicology. 25(4). 473–479. 25 indexed citations
12.
Wright, Colin W., Jonathan Addae-Kyereme, John E. Brown, et al.. (2001). Synthesis and Evaluation of Cryptolepine Analogues for Their Potential as New Antimalarial Agents. Journal of Medicinal Chemistry. 44(19). 3187–3194. 166 indexed citations
13.
Double, John A., et al.. (2001). A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9. British Journal of Cancer. 85(8). 1137–1146. 47 indexed citations
14.
Calabrese, Christopher, Paul M. Loadman, Lee Yong Lim, et al.. (1999). In Vivo Metabolism of the Antitumor Imidazoacridinone C1311 in the Mouse and In Vitro Comparison with Humans. Drug Metabolism and Disposition. 27(2). 240–245. 11 indexed citations
15.
Clarke, Stephen E., et al.. (1999). Aldehyde Oxidase-catalysed Oxidation of Methotrexate in the Liver of Guinea-pig, Rabbit and Man. Journal of Pharmacy and Pharmacology. 51(4). 411–418. 73 indexed citations
16.
Hanks, Steven K., et al.. (1993). Methods for liquid chromatographic analysis of tamoxifen, tamoxifen metabolites and their geometric isomers in biological samples. Analytical Proceedings. 30(3). 161–163. 1 indexed citations
17.
Brown, John E., et al.. (1990). Portrait of Lynn (as Josephus Would Wish it). Callaloo. 13(4). 756–756. 1 indexed citations
18.
Jones, Simon S., et al.. (1987). Automating the Purification and Isolation of Synthetic DNA. Nature Biotechnology. 5(1). 67–70. 5 indexed citations
19.
Brown, John E., Paul A. Wilkinson, & Jeffrey Brown. (1981). Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 226(2). 521–525. 23 indexed citations
20.
Bell, Eugene & John E. Brown. (1972). RNA polymerase activities in the cytoplasm of differentiating chick muscle cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 269(2). 237–246. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026